Glycoprize MV 1 Tablet SR
Marketer
Mnicro Labs Pvt. Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Glycoprize MV 1 Tablet SR
Diabex Duo 1 Tablet XR, an antidiabetic medication, combines multiple agents to manage type 2 diabetes in adults. This formulation aids in regulating blood glucose. Administer Diabex Duo 1 Tablet XR with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, risking complications like nephropathy, retinopathy, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Commonly, Diabex Duo 1 Tablet XR may cause hypoglycemia (low blood sugar). Learn to recognize hypoglycemic symptoms—sweating, dizziness, headache, tremors—and how to treat them. Maintain regular meals and carry a readily available fast-acting carbohydrate source (e.g., glucose tablets, fruit juice). Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain is also possible. Diabex Duo 1 Tablet XR is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended by your physician.
Uses of Glycoprize MV 1 Tablet SR
Managing type 2 diabetes
Major Benefits of Glycoprize MV 1 Tablet SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Glycoprize MV 1 Tablet SR on an empty stomach.
Common Side effects of Glycoprize MV 1 Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glycoprize MV 1 Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glycoprize MV 1 Tablet SR should be administered on an empty stomach.
How Glycoprize MV 1 Tablet SR works:
Glycoprize MV 1 Tablet, sustained-release formulation, contains a triple combination of antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glycoprize MV 1 Tablet SR and alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Glycoprize MV 1 Tablet SR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing this medication. Seek medical advice before taking this drug.
Breast feedingCONSULT YOUR DOCTOR
Lactation and Glycoprize MV 1 Tablet SR (sustained-release) are likely incompatible. Available human data indicates potential drug transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Employing Glycoprize MV 1 Tablet SR is likely inadvisable for individuals with impaired renal function and should be omitted. A physician's consultation is recommended. Furthermore, its use is discouraged in patients exhibiting severely compromised kidney function.
LiverCAUTION
Patients with liver impairment should use Glycoprize MV 1 Tablet SR cautiously, potentially requiring dosage modification. Medical advice is recommended. For those with mild to moderate liver disease, a low initial dose of Glycoprize MV 1 Tablet SR is typical; however, it's unsuitable for patients exhibiting severe hepatic dysfunction.
What if you forget to take Glycoprize MV 1 Tablet SR :
Should you forget a Glycoprize MV 1 Tablet SR dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glycoprize MV 1 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |


